News

Filter

Current filters:

None

73 to 82 of 97841 results

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

20-02-2015

Confirming what the media had been saying most of the week, French pharma major Sanofi late yesterday…

BayerBoardroomManagementPharmaceuticalSanofi

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

20-02-2015

Japanese drug major Astellas has published results of a study demonstrating that early and sustained…

AdvagrafAstellasNephrology and HepatologyPharmaceuticalResearch

NewLink earns $20 million Ebola vaccine milestone from Merck

19-02-2015

US biotech firm NewLink Genetics says it had received notification from pharma giant Merck & Co that…

BiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesVaccines

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

19-02-2015

Positive data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first…

BiosimilarsBiotechnologyGastro-intestinalsHospiraInflectraJohnson & JohnsonMerck & CoRemicadeResearch

Genmab inks DuoBody deal with BioNovion in the field of immuno-oncology

19-02-2015

Danish biotech company Genmab has entered into a co-development and commercialization agreement with…

BioNovionBiotechnologyDuoBodyGenmabImmunologicalsLicensingOncologyResearch

Kymab appoints Anne Hyland as chief financial officer

Kymab appoints Anne Hyland as chief financial officer

19-02-2015

Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne…

BiotechnologyBoardroomKymabPharmaceuticalUK

NICE sets too high a QALY cost for NHS drugs, new research claims

NICE sets too high a QALY cost for NHS drugs, new research claims

19-02-2015

The price the National Heath Service in England agrees to pay for new medicines is too high, causing…

HealthcarePharmaceuticalPricingUK

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

19-02-2015

US biotech Regeneron Pharmaceuticals today announced results from a study which show Eylea (aflibercept)…

AvastinEyleaLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsResearchUSA

Sales up but earnings down at SOBI in quarterly and full-year financials

Sales up but earnings down at SOBI in quarterly and full-year financials

19-02-2015

Biotech firm SOBI has reported its fourth quarter and full-year 2014 financial results showing a loss.

BiotechnologyBusiness FinanceFinancialOrfadinSobiSweden

73 to 82 of 97841 results

COMPANY SPOTLIGHT

Menarini

Back to top